Lee Financial’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-213
Closed -$3.07K 608
2023
Q4
$3.07K Buy
213
+191
+868% +$2.6K ﹤0.01% 652
2023
Q3
$382 Hold
22
﹤0.01% 810
2023
Q2
$458 Hold
22
﹤0.01% 746
2023
Q1
$518 Sell
22
-30
-58% -$806 ﹤0.01% 756
2022
Q4
$1.45K Hold
52
﹤0.01% 748
2022
Q3
$1K Sell
52
-28
-35% -$845 ﹤0.01% 772
2022
Q2
$3K Sell
80
-18
-18% -$630 ﹤0.01% 636
2022
Q1
$3K Buy
98
+22
+29% +$752 ﹤0.01% 588
2021
Q4
$2K Hold
76
﹤0.01% 764
2021
Q3
$2K Buy
76
+24
+46% +$768 ﹤0.01% 636
2021
Q2
$2K Buy
+52
New +$1.71K ﹤0.01% 599

Other funds holding OGN

Lee Financial's OGN Position: Q1 2024 in Review

Lee Financial sold out of Organon & Co (OGN) in Q1 2024, closing a stake of 213 shares — an estimated $3.07K sold.

Lee Financial first reported a position in OGN in Q2 2021 and held it in 11 quarters. The position peaked at $3.07K in Q4 2023. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2024.

  • Lee Financial reported no remaining Organon & Co position as of Q1 2024 after selling out during the quarter.
  • Lee Financial sold 213 Organon & Co shares in Q1 2024, an estimated $3.07K.
  • Lee Financial first reported a position in Organon & Co in Q2 2021 and held it in 11 quarters.
  • Lee Financial's Organon & Co position peaked at $3.07K in Q4 2023.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2024.

Based on Lee Financial's 13F filing for Q1 2024, filed 15 May 2024.